07 Jan 2001

Cefavora® (Cefavora® Tropfen) - Deutschland

Cefavora® Description, Presentation and Dosage

Cefavora® Description

Cefavora® Drug Class Description


Cefavora® Drug Description

100 g enth.: Ginkgo biloba 'Urtink.' 1,3 g, Viscum album 'Urtink.' 2,7 g, Crataegus 'Urtink.' 7,5 g.

Cefavora® Generic Name

Cefavora® Tropfen

Cefavora® Presentation

Cefavora® Presentation


Cefavora® Manufacturer


Related Learning Zones



The Hypogonadism Knowledge Centre gives healthcare professionals free access to resources on the diagnosis, treatment and monitoring of patients with the condition. The regularly-updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Cefavora® Dosage

Cefavora® Adult Dosage


Cefavora® Precautions, Reactions and Contraindications

Cefavora® Special Precautions

Related Drugs - Angiology

Back to top